We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-10.69%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$87.8M
AUM Growth
-$16.5M
Cap. Flow
-$5.01M
Cap. Flow %
-5.71%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CMPS
Compass Pathways
CMPS
+$5.01M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$75.6M 86.1%
3,773,530
CMPS
2
Compass Pathways
CMPS
$2.04B
$12.2M 13.9%
408,410
-149,350
-27% -$5.01M

Similar funds

Founders Fund VII Management's Q3 2021 Portfolio in Review

As of Q3 2021, Founders Fund VII Management held 2 positions worth $87.8M, down 16% from $104M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund VII Management withdrew a net $5.01M in Q3 2021, reducing 1 holding. Its largest reduction was Compass Pathways, cutting an estimated $5.01M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's biggest Q3 2021 reduction was Compass Pathways, cutting an estimated $5.01M.
  • Founders Fund VII Management's ten largest holdings make up 100% of its $87.8M portfolio in Q3 2021.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q3 2021.
  • Founders Fund VII Management's portfolio value fell 16% quarter-over-quarter to $87.8M.

Based on Founders Fund VII Management's 13F filing for Q3 2021, filed 15 Nov 2021.